시장보고서
상품코드
1576636

세계의 압박요법 시장 규모, 점유율, 예측, 동향 분석 : 제품별(붕대, 스타킹, 테이프, 펌프) 시술별(정적, 동적) 상태별(하지정맥류, 림프부종, 하지궤양) 유통별(전자상거래, 병원) - 예측(-2030년)

Compression Therapy Market Size, Share, Forecast, & Trends Analysis by Product (Bandages, Stockings, Tapes, Pumps) Technique (Static, Dynamic) Condition (Varicose Vein, Lymphedema, Leg Ulcer) Distribution (E-commerce, Hospital) - Global Forecast to 2030

발행일: | 리서치사: Meticulous Research | 페이지 정보: 영문 270 Pages | 배송안내 : 5-7일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

압박 요법 시장은 2024년부터 2030년까지 3.8%의 연평균 복합 성장률(CAGR)로 성장하여 2030년에는 58억 8,000만 달러에 달할 것으로 예측됩니다.

우리는 광범위한 1차 및 2차 연구를 수행하여 압박 요법 시장 시나리오를 상세하게 분석했습니다. 이 보고서는 업계의 주요 동인, 저해요인, 과제와 기회 요인을 분석합니다. 압박 요법 시장의 성장은 주로 노인 인구 증가, 만성 질환 유병률 증가, 스포츠 외상 및 사고 증가, 정형외과 수술 증가에 의해 주도되고 있습니다. 또한 하지정맥류 및 심부정맥혈전증(DVT) 사례 증가, 예방책으로 압박요법 제품의 점진적인 수용, 압박요법의 최소한의 부작용과 광범위한 혜택은 이 시장의 성장을 더욱 촉진하고 있습니다.

또한, 신흥국은 이 시장에서 활동하는 기업들에게 큰 성장 기회를 제공할 것으로 예상됩니다. 그러나 대체 기술 채택과 압박 요법에 대한 불충분한 상환 구조는 시장 성장에 영향을 미치는 주요 과제입니다.

이 보고서는 4년간(2020-2024년) 제품 포트폴리오 제공, 지역 상황, 업계 선도 기업들이 채택한 주요 전략 개발 등 광범위한 평가를 바탕으로 한 경쟁 환경을 제공합니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 시장 성장 요인

  • 개요
    • 성장 촉진요인
    • 성장 억제요인
    • 기회
    • 과제
  • 요인 분석
  • 규제 분석
  • 업계와 기술 동향
  • 가격 분석
  • Porter의 Five Forces 분석

제5장 압박 요법 시장 평가 : 제품별

  • 개요
  • 붕대
  • 가먼트
    • 스타킹
      • 클래스 I
      • 클래스 II
      • 클래스 III
    • Socks & Sleeves
    • Wraps & Tapes
    • 기타 가먼트
  • 간헐식/연속식 공기압축 펌프
    • 비분할형 공기압축 펌프
    • 분할형 공기압축 펌프
  • 기타 압박 펌프

제6장 압박 요법 시장 평가 : 시술별

  • 개요
  • 정적 압박 요법
  • 동적 압박 요법

제7장 압박 요법 시장 평가 : 증상별

  • 개요
  • 하지정맥류
  • 심부정맥 혈전증
  • 림프액 부종
  • 종아리 궤양
  • 기타 증상

제8장 압박 요법 시장 평가 : 유통 채널별

  • 개요
  • 병원 및 진료소
  • 약국 및 소매업체
  • E-Commerce
  • 기타 유통 채널

제9장 압박 요법 시장 : 시설별

  • 개요
  • 의료 제공업체
  • 재택치료

제10장 압박 요법 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 스위스
    • 네덜란드
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 호주
    • 한국
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타 라틴아메리카
  • 중동 및 아프리카

제11장 경쟁 분석

  • 개요
  • 주요 성장 전략
  • 경쟁 벤치마킹
  • 경쟁 대시보드
    • 업계 리더
    • 차별화 요인
    • 선구 기업
    • 신규 기업
  • 주요 기업의 시장 점유율 분석/시장 순위(2022년)

제12장 기업 개요(기업 개요, 재무 개요, 제품 포트폴리오, 전략 전개 상황, SWOT 분석*).

  • 3M Company
  • Essity Aktiebolag(publ)
  • Bio Compression Systems, Inc.
  • Arjo AB
  • Convatec Inc.
  • Cardinal Health, Inc.
  • PAUL HARTMANN AG
  • Medline Industries, Inc.
  • Julius Zorn, Inc.
  • DJO, LLC
  • Smith & Nephew plc
  • medi GmbH & Co. KG
  • SIGVARIS AG

(주 : 주요 5개사의 SWOT 분석을 게재)

제13장 부록

LSH 24.11.12

Compression Therapy Market Size, Share, Forecast, & Trends Analysis by Product (Bandages, Stockings, Tapes, Pumps) Technique (Static, Dynamic) Condition (Varicose Vein, Lymphedema, Leg Ulcer) Distribution (E-commerce, Hospital)-Global Forecast to 2030

The compression therapy market is expected to reach $5.88 billion by 2030, at a CAGR of 3.8% from 2024 to 2030.

Following extensive secondary and primary research and in-depth analysis of the compression therapy market scenario. This report analyzes key industry drivers, restraints, challenges, and opportunities. The growth of the compression therapy market is primarily driven by the rising geriatric population, the increasing prevalence of chronic diseases, the growing number of sports injuries & accidents, and the growth in orthopedic procedures. In addition, the increasing cases of varicose veins and deep vein thrombosis (DVT), the gradual acceptance of compression therapy products as a preventive measure, and the minimal side effects and wide-ranging benefits of compression therapy further support the growth of this market.

Furthermore, emerging economies are expected to provide significant growth opportunities for the players operating in this market. However, the adoption of alternative technologies and an inadequate reimbursement structure for compression therapies are some of the major challenges impacting the market growth.

This report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the compression therapy market are 3M Company (U.S.), Essity Aktiebolag (publ) (Sweden), Bio Compression Systems, Inc. (U.S.), Arjo AB (Sweden), Convatec Inc. (U.S.), Cardinal Health, Inc. (U.S.), PAUL HARTMANN AG (Germany), Medline Industries, Inc. (U.S.), Julius Zorn, Inc. (U.S.), DJO, LLC (U.S.), Smith & Nephew plc (U.K.), medi GmbH & Co. KG (Germany), and SIGVARIS AG (Switzerland).

Based on product, the compression therapy market is segmented into bandages, garments, sequential/intermittent pneumatic compression pumps, and other pressure pumps. In 2024, the garments segment is expected to account for the largest share of 41% of the compression therapy market. The segment's large share is driven by the growing geriatric population with chronic diseases such as diabetes and varicose veins. According to data from the International Diabetes Federation (IDF) Diabetes Atlas, the prevalence of diabetes in individuals aged 20-79 years is expected to increase to 517 million in 2045 from 463 million in 2019. Additionally, the increased demand for compression therapy garments among healthcare professionals and the general population for long-term treatment options also contributes to the segment's large market share.

Based on technique, the compression therapy market is segmented into static and dynamic compression therapy. In 2024, the static compression therapy segment is expected to account for the larger share of the compression therapy market. The segment's large share is attributed to the widespread adoption of static compression therapy due to its benefits, including enhanced comfort during extended use, cost-effectiveness, user-friendly application, and the reliable delivery of consistent pressure.

Based on condition, the compression therapy market is segmented into varicose veins, deep vein thrombosis, lymphedema, and leg ulcers. In 2024, the varicose veins segment is expected to account for the largest share of the compression therapy market. The segment's large share is attributed to the rising geriatric population prone to vein-related disorders, the increase in secondary disorders associated with vein issues, and the rising prevalence of obese individuals who are at a higher risk of developing varicose veins.

Based on distribution channel, the compression therapy market is segmented into hospitals & clinics, pharmacies & retailers, e-commerce, and other distribution channels. In 2024, the pharmacies & retailers segment is expected to account for the largest share of the compression therapy market. The segment's large share is attributed to the growing demand for compression therapy products and their wide accessibility through pharmacies that operate around the clock.

Based on facility, the compression therapy market is segmented into healthcare settings and home-care settings. In 2024, the healthcare settings segment is expected to account for the larger share of the compression therapy market. This segment's large share is attributed to healthcare providers' recommendations to use compression therapy solutions for people at risk of deep vein thrombosis and obesity, and the use of compression solutions to manage chronic venous insufficiency.

An in-depth analysis of the geographical scenario of the compression therapy market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each area.

Based on geography, the compression therapy market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The Asia-Pacific market is slated to register the highest growth rate during the forecast period due to growing markets such as India (CAGR 5.9%) and China (CAGR 6.1%). The growth of this regional market is attributed to the extensive use of compression therapy among the region's elderly population, particularly those dealing with orthopedic issues, injuries, or secondary conditions such as obesity, hypertension, and post-diabetic blood problems.

Scope of the Report:

Compression Therapy Market Assessment-by Product

  • Bandages
  • Garments
    • Stockings
  • Class I
  • Class II
  • Class III
    • Socks & Sleeves
    • Wraps & Tapes
    • Other Garments
  • Intermittent/Sequential Pneumatic Compression Pumps
    • Non-segmented Pneumatic Compression Pumps
    • Segmented Pneumatic Compression Pumps
  • Other Pressure Pumps

Note: Other garments include inflatable devices, liners, bands, belts, braces, and tubes.

Compression Therapy Market Assessment-by Technique

  • Static Compression Therapy
  • Dynamic Compression Therapy

Compression Therapy Market Assessment-by Condition

  • Varicose Veins
  • Deep Vein Thrombosis
  • Lymphedema
  • Leg Ulcers
  • Other Conditions

Note: Other Conditions include Orthostatic Hypotension, Postural Hypotension, Dysautonomia (POTS), Ehlers-Danlos Syndrome (EDS), May-Thurner Syndrome (MTS), and Post-thrombotic Syndrome (PTS).

Compression Therapy Market Assessment-by Distribution Channel

  • Hospitals & Clinics
  • Pharmacies & Retailers
  • E-commerce
  • Other Distribution Channels

Note: Other distribution channels include nursing care centers and home care settings.

Compression Therapy Market Assessment-by Facility

  • Healthcare Settings
  • Home-care Settings

Compression Therapy Market Assessment-by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Spain
    • Switzerland
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition & Scope
  • 1.2. Market Ecosystem
  • 1.3. Currency & Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Data Collection & Validation Process
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
  • 2.3. Market Sizing & Forecasting
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Factors Affecting Market Growth

  • 4.1. Overview
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Geriatric Population
      • 4.1.1.2. Growing Number of Sports & Accident Injuries
      • 4.1.1.3. Rising Number of Orthopedic Procedures
      • 4.1.1.4. Increasing Cases of Varicose Veins and Deep Vein Thrombosis (DVT)
      • 4.1.1.5. Growing Acceptance of Compression Therapy Products as a Preventive Measure
      • 4.1.1.6. Minimal Side Effects & Wide-ranging Benefits of Compression Therapy
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Adherence to Compression Therapy Among Patients
      • 4.1.2.2. High Costs of Compression Therapy Garments
      • 4.1.2.3. Lack of Awareness About Compression Therapy
    • 4.1.3. Opportunities
      • 4.1.3.1. Emerging Economies
    • 4.1.4. Challenges
      • 4.1.4.1. Use of Alternative Technologies
      • 4.1.4.2. Inadequate Reimbursement Structure for Compression Therapies
  • 4.2. Factor Analysis
  • 4.3. Regulatory Analysis
  • 4.4. Industry & Technology Trends
  • 4.5. Pricing Analysis
  • 4.6. Porter's Five Forces Analysis

5. Compression Therapy Market Assessment-by Product

  • 5.1. Overview
  • 5.2. Bandages
  • 5.3. Garments
    • 5.3.1. Stockings
      • 5.3.1.1. Class I
      • 5.3.1.2. Class II
      • 5.3.1.3. Class III
    • 5.3.2. Socks & Sleeves
    • 5.3.3. Wraps & Tapes
    • 5.3.4. Other Garments
  • 5.4. Intermittent/Sequential Pneumatic Compression Pumps
    • 5.4.1. Non-segmented Pneumatic Compression Pumps
    • 5.4.2. Segmented Pneumatic Compression Pumps
  • 5.5. Other Pressure Pumps

6. Compression Therapy Market Assessment-by Technique

  • 6.1. Overview
  • 6.2. Static Compression Therapy
  • 6.3. Dynamic Compression Therapy

7. Compression Therapy Market Assessment-by Condition

  • 7.1. Overview
  • 7.2. Varicose Veins
  • 7.3. Deep Vein Thrombosis
  • 7.4. Lymphedema
  • 7.5. Leg Ulcers
  • 7.6. Other Conditions

8. Compression Therapy Market Assessment-by Distribution Channel

  • 8.1. Overview
  • 8.2. Hospitals & Clinics
  • 8.3. Pharmacies & Retailers
  • 8.4. E-commerce
  • 8.5. Other Distribution Channels

9. Compression Therapy Market Assessment-by Facility

  • 9.1. Overview
  • 9.2. Healthcare Providers
  • 9.3. Home-care Settings

10. Compression Therapy Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Switzerland
    • 10.3.7. Netherlands
    • 10.3.8. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. India
    • 10.4.3. Japan
    • 10.4.4. Australia
    • 10.4.5. South Korea
    • 10.4.6. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competition Analysis

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share Analysis/Market Rankings of Leading Players (2022)

12. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

  • 12.1. 3M Company
  • 12.2. Essity Aktiebolag (publ)
  • 12.3. Bio Compression Systems, Inc.
  • 12.4. Arjo AB
  • 12.5. Convatec Inc.
  • 12.6. Cardinal Health, Inc.
  • 12.7. PAUL HARTMANN AG
  • 12.8. Medline Industries, Inc.
  • 12.9. Julius Zorn, Inc.
  • 12.10. DJO, LLC
  • 12.11. Smith & Nephew plc
  • 12.12. medi GmbH & Co. KG
  • 12.13. SIGVARIS AG

(Note: SWOT analyses of the top 5 companies will be provided.)

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제